tipifarnib has been researched along with prednisone in 1 studies
| Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (prednisone) | Trials (prednisone) | Recent Studies (post-2010) (prednisone) |
|---|---|---|---|---|---|
| 309 | 92 | 94 | 41,222 | 5,274 | 8,409 |
| Protein | Taxonomy | tipifarnib (IC50) | prednisone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 1.146 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.146 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 other study(ies) available for tipifarnib and prednisone
| Article | Year |
|---|---|
48th annual meeting of the American Society of Hematology December 9-12, 2006, Orlando, FL.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Progression; Drug Therapy, Combination; Hematologic Diseases; Hematology; Humans; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Pyrazines; Quinolones; Recurrence; Stem Cell Transplantation; Thalidomide; Transplantation Conditioning; Transplantation, Autologous | 2007 |